Proimmune, Inc.

Sarasota, FL

UEI
C97DJ9NYBGV9
CAGE
4V3U8
Primary NAICS
541690 Other Scientific and Technical Consulting Services
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Foreign Owned
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
4281 Express Ln l2378, Sarasota, FL 34249, USA
Website
proimmune.com
Founded
2000
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Life Sciences Tools & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 -$5,267

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Proimmune, Inc. - doing business as Proimmune Inc. is a company that specializes in understanding and managing immune responses. They offer products and services for immunology research, including MHC pentamers, CD1d tetramers, custom peptide synthesis, immunoassays, T cell epitope mapping, and more. Through past federal contract awards, Proimmune has provided a variety of immunology research services to the Department of Health and Human Services, including the Food and Drug Administration (FDA) and National Institutes of Health. These services have included T cell proliferation assays, MHC class II peptide proteomics assays, HLA typing, and analyzing FVIII-derived peptides. Several contracts were set aside for small businesses. Partners have included Veterans Integrated Service Network 20 and Veterans Health Administration.

Quick answers

Is Proimmune, Inc. registered in SAM.gov?

Yes. Proimmune, Inc.'s SAM.gov registration is active through October 12, 2027.

What is Proimmune, Inc.'s most recent federal award?

Proimmune, Inc.'s most recent federal contract award is Research services for: the application of a pre-clinical assay for comparing immune response to CAS proteins derived… (75F40122C00199), from Food and Drug Administration, on September 23, 2022.

On GovTribe

See Proimmune, Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors